Viatris

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$6.85-$13.38
Market Cap
$9B
Shares Short
44M

Financials

See more
Revenue (12 Mos)
$14.7B
Revenue Growth (YoY)
-8.1%
Gross Profit (12 Mos)
$6.1B
Diluted EPS
-$0.53

News

See more

Yahoo Finance • 1 hour ago

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

Yahoo Finance • 24 hours ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

Yahoo Finance • yesterday

VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit -- Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)

Yahoo Finance • 2 days ago

VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

About

CEO
Mr. Scott Andrew Smith Ph.D.
Address
Robert J. Coury Global Center, Canonsburg, PA, United States, 15317
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
32,000